|
|
Volumn 6, Issue 1, 2003, Pages 152-163
|
|
Ethical and regulatory issues concerning engineered tissues for congenital heart repair.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOPROSTHESIS;
CARDIOVASCULAR SURGERY;
COMPARATIVE STUDY;
CONGENITAL HEART MALFORMATION;
ETHICS;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART VALVE PROSTHESIS;
HUMAN;
LEGAL ASPECT;
MALE;
METHODOLOGY;
MORTALITY;
NEWBORN;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
SURVIVAL;
TISSUE ENGINEERING;
XENOGRAFT;
BIOPROSTHESIS;
CARDIOVASCULAR SURGICAL PROCEDURES;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART DEFECTS, CONGENITAL;
HEART VALVE PROSTHESIS;
HUMANS;
INFANT, NEWBORN;
MALE;
PROGNOSIS;
RISK ASSESSMENT;
SURVIVAL ANALYSIS;
TISSUE ENGINEERING;
TRANSPLANTATION, HETEROLOGOUS;
MLCS;
MLOWN;
|
|
EID: 0141888124
PISSN: 10929126
EISSN: None
Source Type: Journal
DOI: 10.1016/s1092-9126(03)70019-2 Document Type: Review |
|
Times cited : (9)
|
|
References (47)
|
